{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:19:04Z","timestamp":1794590344332,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13048-016-0257-4","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T00:20:54Z","timestamp":1469838054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review"],"prefix":"10.1186","volume":"9","author":[{"given":"T.","family":"Burnik Papler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Frkovi\u0107 Grazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kobal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,30]]},"reference":[{"key":"257_CR1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","volume":"9","author":"RH Young","year":"1985","unstructured":"Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors.A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985;9:543\u201369.","journal-title":"Am J Surg Pathol"},{"key":"257_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1097-0142(19810701)48:1<187::AID-CNCR2820480130>3.0.CO;2-1","volume":"48","author":"LM Roth","year":"1981","unstructured":"Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli - Leydig cell tumors a clinicopathologic study of 34 cases. Cancer. 1981;48:187\u201397.","journal-title":"Cancer"},{"key":"257_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00006254-197103000-00001","volume":"26","author":"RH Osborn","year":"1971","unstructured":"Osborn RH, Yannone ME. Plasma androgens in the normal and androgenic female: A review. Obstet Gynecol Surv. 1971;26:195\u2013228.","journal-title":"Obstet Gynecol Surv"},{"key":"257_CR4","first-page":"6956","volume":"7","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Zhu JE, Huang W, Zhu J. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors. Int J Clin Exp Pathol. 2014;7:6956\u201364.","journal-title":"Int J Clin Exp Pathol"},{"key":"257_CR5","first-page":"129","volume":"7","author":"KM Zanotti","year":"2002","unstructured":"Zanotti KM. The clinical manifestations and diagnosis of Sertoli-Leydig cell tumors of the ovary. CME J Gynecol Oncol. 2002;7:129\u201333.","journal-title":"CME J Gynecol Oncol"},{"key":"257_CR6","volume-title":"WHO classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington S, Zoung RH. WHO classification of tumours of female reproductive organs. Lyon: IARC; 2014."},{"key":"257_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.pgp.0000192271.22289.e6","volume":"25","author":"LM Roth","year":"2006","unstructured":"Roth LM. Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2006;25:199\u2013215.","journal-title":"Int J Gynecol Pathol"},{"key":"257_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mpdhp.2008.06.011","volume":"14","author":"N Wilkinson","year":"2008","unstructured":"Wilkinson N, Osborn S, Youngh RH. Sex cord-stromal tumours of the ovary: a review highlighting recent advances. Diagn Histopathol. 2008;14:388\u2013400.","journal-title":"Diagn Histopathol"},{"key":"257_CR9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10147-011-0186-6","volume":"16","author":"W Lou","year":"2011","unstructured":"Lou W, Cao D, Yang J, Guo L, Shen K. Retiform Sertoli-Leydig cell tumor of ovary in a 9-year-old girl: case report and review of the literature. Int J Clin Oncol. 2011;16:705\u20138.","journal-title":"Int J Clin Oncol"},{"key":"257_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004347-199304000-00009","volume":"12","author":"RH Young","year":"1993","unstructured":"Young RH. Sertoli-Leydig cell tumors of the ovary: Review with emphasis on historical aspects and unusual variants. Int J Gynecol Pathol. 1993;12:141\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"257_CR11","doi-asserted-by":"crossref","first-page":"111ps46","DOI":"10.1126\/scitranslmed.3002493","volume":"3","author":"A Bahubeshi","year":"2011","unstructured":"Bahubeshi A, Tischkowitz M, Foulkes WD. MiRNA processing and human cancer: DICER 1 cuts the mustard. Sci Transl Med. 2011;3:111ps46.","journal-title":"Sci Transl Med"},{"key":"257_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1102903","volume":"366","author":"A Heravi\u2013Moussavi","year":"2012","unstructured":"Heravi\u2013Moussavi A, Anglesio MS, Cheng Grace SW, Senz J, Yang W, et al. Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers. N Engl J Med. 2012;366:234\u201342.","journal-title":"N Engl J Med"},{"key":"257_CR13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2010.081216","volume":"47","author":"A Bahubeshi","year":"2010","unstructured":"Bahubeshi A, Bal N, Rio Frio T, Hamel N, Pouchet C, Yilmaz A, Bouron-Dal Soglio D, Williams GM, Tischkowitz M, Priest JR, Foulkes WD. Germline DICER1 mutations and familial cystic nephroma. J Med Genet. 2010;47:863\u20136.","journal-title":"J Med Genet"},{"key":"257_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2010.1910","volume":"305","author":"T Rio Frio","year":"2011","unstructured":"Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 2011;305:68\u201377.","journal-title":"JAMA"},{"key":"257_CR15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/modpathol.2015.115","volume":"28","author":"N Conlon","year":"2015","unstructured":"Conlon N, Schultheis AM, Piscuoglio S, Silva A, Guerra E, Tornos C, Reuter VE, Soslow RA, Young RH, Oliva E, Weigelt B. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Mod Pathol. 2015;28:1603\u201312.","journal-title":"Mod Pathol"},{"key":"257_CR16","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","volume":"359","author":"WM Merritt","year":"2008","unstructured":"Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008;359:2641\u201350.","journal-title":"N Engl J Med"},{"key":"257_CR17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2559.2002.01426.x","volume":"41","author":"EE Mooney","year":"2002","unstructured":"Mooney EE, Nogales FF, Bergeron C, Tavassoli FA. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology. 2002;41:110\u20137.","journal-title":"Histopathology"},{"key":"257_CR18","first-page":"465","volume":"50","author":"J Prat","year":"1982","unstructured":"Prat J, Young RH, Scully RE. Ovarian Sertoli- Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer. 1982;50:465\u201375.","journal-title":"Cancer"},{"key":"257_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1447-0756.2012.01928.x","volume":"39","author":"RA Bhat","year":"2013","unstructured":"Bhat RA, Lim YK, Chia YN, Yam KL. Sertoli- Leydig cell tumor of the ovary: analysis of a single institution database. J Obstet Gynaecol Res. 2013;39:305\u201310.","journal-title":"J Obstet Gynaecol Res"},{"key":"257_CR20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2012.07.114","volume":"127","author":"T Gui","year":"2012","unstructured":"Gui T, Cao D, Shen K, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 2012;127:384\u20139.","journal-title":"Gynecol Oncol"},{"key":"257_CR21","first-page":"383","volume-title":"Ovarian Cancer 2001","author":"PE Schwartz","year":"2001","unstructured":"Schwartz PE, Price FV, Snyder MK. Management of ovarian stromal tumors. In: Rubin SC, Sutton GR, editors. Ovarian Cancer 2001. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 383\u201398.","edition":"2"},{"key":"257_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.pgp.0000236947.59463.87","volume":"26","author":"WG McCluggage","year":"2007","unstructured":"McCluggage WG, McKenna M, McBride HA. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2007;26:322\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"257_CR23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.anndiagpath.2005.09.012","volume":"10","author":"A Grove","year":"2006","unstructured":"Grove A, Vestergaard V. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature. Ann Diagn Pathol. 2006;10:288\u201393.","journal-title":"Ann Diagn Pathol"},{"key":"257_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1034\/j.1600-0412.2003.00021.x","volume":"82","author":"E Kostopoulou","year":"2003","unstructured":"Kostopoulou E, Talerman A. Ovarian Sertoli-Leydig cell tumor of intermediate differentiation with immature skeletal muscle heterologous elements. Acta Obstet Gynecol Scand. 2003;82:197\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"257_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/01913128209018557","volume":"3","author":"MJ Guerard","year":"1982","unstructured":"Guerard MJ, Ferenczy A. Ovarian Sertoli-Leydig cell tumor with rhabdomyosarcoma: an ultrastructural study. Ultrastruct Pathol. 1982;3:347\u201358.","journal-title":"Ultrastruct Pathol"},{"key":"257_CR26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2013.06.034","volume":"131","author":"EM George","year":"2013","unstructured":"George EM, Herzog TJ, Neugut AI, Lu YS, Burke WM, Lewin SN, Hershman DL, Wright JD. Carcinosarcoma of the Ovary: Natural History, Patterns of Treatment, and Outcome. Gynecol Oncol. 2013;131:42\u20135.","journal-title":"Gynecol Oncol"},{"key":"257_CR27","first-page":"1316","volume":"124","author":"Y Dai","year":"2011","unstructured":"Dai Y, Shen K, Lang JH, Huang HF, Pan LY, Wu M, Yang JX, Zhong DR. Primary sarcoma of the ovary: clinicopathological characteristics, prognostic factors and evaluation of therapy. Chin Med J. 2011;124:1316\u201321.","journal-title":"Chin Med J"},{"key":"257_CR28","doi-asserted-by":"crossref","first-page":"490508","DOI":"10.1155\/2013\/490508","volume":"2013","author":"AM Jernigan","year":"2013","unstructured":"Jernigan AM, Fader AN, Nutter B, Rose P, Tseng JH, Escobar PF. Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survival. Obstet Gynecol Int. 2013;2013:490508.","journal-title":"Obstet Gynecol Int"},{"key":"257_CR29","first-page":"7303","volume":"34","author":"N Bacalbasa","year":"2014","unstructured":"Bacalbasa N, Balescu I, Dima S, Popescu I. Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case\u2013control matched study. Anticancer Res. 2014;34:7303\u20138.","journal-title":"Anticancer Res"},{"key":"257_CR30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00404-010-1404-6","volume":"283","author":"HS Pan","year":"2011","unstructured":"Pan HS, Lee SL, Huang LW, Chen YK. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer. Arch Gynecol Obstet. 2011;283:335\u201341.","journal-title":"Arch Gynecol Obstet"},{"key":"257_CR31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","volume":"71","author":"P Gu","year":"2009","unstructured":"Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71:164\u201374.","journal-title":"Eur J Radiol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-016-0257-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:32:46Z","timestamp":1498332766000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-016-0257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1186\/s13048-016-0257-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,30]]},"article-number":"46"}}